EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors
Clinical trial NCT01251926 · COMPLETED
Trial details
- NCT number
- NCT01251926
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.